# Early Administration of Insulin Glargine in Patients With Diabetic Ketoacidosis

> **NCT06007508** · PHASE2 · TERMINATED · sponsor: **HealthPartners Institute** · enrollment: 8 (actual)

## Conditions studied

- DKA

## Interventions

- **DRUG:** Insulin Glargine

## Key facts

- **NCT ID:** NCT06007508
- **Lead sponsor:** HealthPartners Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-05-31
- **Primary completion:** 2023-02-28
- **Final completion:** 2023-02-28
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Study intervention was adopted as standard of care.
- **Last updated:** 2024-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06007508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06007508, "Early Administration of Insulin Glargine in Patients With Diabetic Ketoacidosis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06007508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*